Moss Adams Wealth Advisors’s NanoViricides NNVC Stock Holding History

Moss Adams Wealth Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.7K	Hold	21,500	–	–	﹤0.01%	304
2026 Q1	$19.6K	Buy	21,500 +1,500	+8%	+$1.57K	﹤0.01%	269
2025 Q4	$22.6K	Buy	20,000 +3,000	+18%	+$4.21K	﹤0.01%	261
2025 Q3	$24.3K	Buy	17,000 +2,000	+13%	+$2.99K	﹤0.01%	254
2025 Q2	$21K	Hold	15,000	–	–	﹤0.01%	254
2025 Q1	$17.6K	Hold	15,000	–	–	﹤0.01%	216
2024 Q4	$21.4K	Hold	15,000	–	–	﹤0.01%	208
2024 Q3	$22.5K	Hold	15,000	–	–	﹤0.01%	203
2024 Q2	$25.8K	Buy	+15,000	New	+$26.7K	﹤0.01%	174
2024 Q1	–	Sell	-12,000	Closed	-$12.2K	–	157
2023 Q4	$12.2K	Hold	12,000	–	–	﹤0.01%	121
2023 Q3	$16.1K	Buy	+12,000	New	+$17K	0.01%	138

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Moss Adams Wealth Advisors's NNVC Position: Q2 2026 in Review

Moss Adams Wealth Advisors held its NanoViricides (NNVC) position steady in Q2 2026 at 21,500 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

Moss Adams Wealth Advisors first reported a position in NNVC in Q3 2023 and has held it in 11 quarters since. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Moss Adams Wealth Advisors held 21,500 shares of NanoViricides worth $29.7K as of Q2 2026.
Moss Adams Wealth Advisors left its NanoViricides share count unchanged in Q2 2026.
NanoViricides made up ﹤0.01% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #304 holding.
Moss Adams Wealth Advisors first reported a position in NanoViricides in Q3 2023 and has held it in 11 quarters since.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.